Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines

Introduction. Flaviviruses, possessing natural neurotropicity could be used in glioblastoma therapy using attenuated strains or as a delivery system for antitumor agents in an inactivated form. Objective. To investigate the sensitivity of glioblastoma and pancreatic carcinoma cell lines to vaccin...

Full description

Bibliographic Details
Main Authors: Alina S. Nazarenko, Yulia K. Biryukova, Ekaterina O. Orlova, Kirill N. Trachuk, Alla L. Ivanova, Alla V. Belyakova, Nikolai B. Pestov, Mikhail F. Vorovitch, Aydar A. Ishmukhametov, Nadezhda M. Kolyasnikova
Format: Article
Language:English
Published: Central Research Institute for Epidemiology 2023-12-01
Series:Вопросы вирусологии
Subjects:
Online Access:https://virusjour.crie.ru/jour/article/viewFile/16100/850
_version_ 1797372619387830272
author Alina S. Nazarenko
Yulia K. Biryukova
Ekaterina O. Orlova
Kirill N. Trachuk
Alla L. Ivanova
Alla V. Belyakova
Nikolai B. Pestov
Mikhail F. Vorovitch
Aydar A. Ishmukhametov
Nadezhda M. Kolyasnikova
author_facet Alina S. Nazarenko
Yulia K. Biryukova
Ekaterina O. Orlova
Kirill N. Trachuk
Alla L. Ivanova
Alla V. Belyakova
Nikolai B. Pestov
Mikhail F. Vorovitch
Aydar A. Ishmukhametov
Nadezhda M. Kolyasnikova
author_sort Alina S. Nazarenko
collection DOAJ
description Introduction. Flaviviruses, possessing natural neurotropicity could be used in glioblastoma therapy using attenuated strains or as a delivery system for antitumor agents in an inactivated form. Objective. To investigate the sensitivity of glioblastoma and pancreatic carcinoma cell lines to vaccine strains of yellow fever and tick-borne encephalitis viruses. Materials and methods. Cell lines: glioblastoma GL-6, T98G, LN-229, pancreatic carcinoma MIA RaCa-2 and human pancreatic ductal carcinoma PANC-1. Viral strains: 17D yellow fever virus (YF), Sofjin tick-borne encephalitis virus (TBEV). Virus concentration were determined by plaque assay and quantitative PCR. Determination of cell sensitivity to viruses by MTT assay. Results. 17D YF was effective only against pancreatic carcinoma tumor cells MIA Paca-2 and had a limited effect against PANC-1. In glioblastoma cell lines (LN229, GL6, T98G), virus had no oncolytic effect and the viral RNA concentration fell in the culture medium. Sofjin TBEV showed CPE50 against MIA Paca-2 and a very limited cytotoxic effect against PANC-1. However, it had no oncolytic effect against glioblastoma cell lines (LN229, T98G and GL6), although virus reproduction continued in these cultures. For the GL6 glioblastoma cell line, the viral RNA concentration at the level with the infection dose was determined within 13 days, despite medium replacement, while in the case of the LN229 cell line, the virus concentration increased from 1 × 109 to 1 × 1010 copies/ml. Conclusion. Tumor behavior in organism is more complex and is determined by different microenvironmental factors and immune status. In the future, it is advisable to continue studying the antitumor oncolytic and immunomodulatory effects of viral strains 17D YF and Sofjin TBEV using in vivo models.
first_indexed 2024-03-08T18:37:40Z
format Article
id doaj.art-e4def4e6cbf1471bbc5241c08ec63f0d
institution Directory Open Access Journal
issn 0507-4088
2411-2097
language English
last_indexed 2024-03-08T18:37:40Z
publishDate 2023-12-01
publisher Central Research Institute for Epidemiology
record_format Article
series Вопросы вирусологии
spelling doaj.art-e4def4e6cbf1471bbc5241c08ec63f0d2023-12-29T10:39:14ZengCentral Research Institute for EpidemiologyВопросы вирусологии0507-40882411-20972023-12-0168653654810.36233/0507-4088-2041200Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell linesAlina S. Nazarenko0https://orcid.org/0000-0002-7322-8730Yulia K. Biryukova1https://orcid.org/0000-0002-5804-4001Ekaterina O. Orlova2https://orcid.org/0009-0009-4175-0493Kirill N. Trachuk3https://orcid.org/0000-0002-2061-0274Alla L. Ivanova4https://orcid.org/0009-0002-3086-0581Alla V. Belyakova5https://orcid.org/0000-0003-4363-6394Nikolai B. Pestov6https://orcid.org/0000-0002-9973-0120Mikhail F. Vorovitch7https://orcid.org/0000-0002-7367-6357Aydar A. Ishmukhametov8https://orcid.org/0000-0001-6130-4145Nadezhda M. Kolyasnikova9https://orcid.org/0000-0002-9934-2582Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Introduction. Flaviviruses, possessing natural neurotropicity could be used in glioblastoma therapy using attenuated strains or as a delivery system for antitumor agents in an inactivated form. Objective. To investigate the sensitivity of glioblastoma and pancreatic carcinoma cell lines to vaccine strains of yellow fever and tick-borne encephalitis viruses. Materials and methods. Cell lines: glioblastoma GL-6, T98G, LN-229, pancreatic carcinoma MIA RaCa-2 and human pancreatic ductal carcinoma PANC-1. Viral strains: 17D yellow fever virus (YF), Sofjin tick-borne encephalitis virus (TBEV). Virus concentration were determined by plaque assay and quantitative PCR. Determination of cell sensitivity to viruses by MTT assay. Results. 17D YF was effective only against pancreatic carcinoma tumor cells MIA Paca-2 and had a limited effect against PANC-1. In glioblastoma cell lines (LN229, GL6, T98G), virus had no oncolytic effect and the viral RNA concentration fell in the culture medium. Sofjin TBEV showed CPE50 against MIA Paca-2 and a very limited cytotoxic effect against PANC-1. However, it had no oncolytic effect against glioblastoma cell lines (LN229, T98G and GL6), although virus reproduction continued in these cultures. For the GL6 glioblastoma cell line, the viral RNA concentration at the level with the infection dose was determined within 13 days, despite medium replacement, while in the case of the LN229 cell line, the virus concentration increased from 1 × 109 to 1 × 1010 copies/ml. Conclusion. Tumor behavior in organism is more complex and is determined by different microenvironmental factors and immune status. In the future, it is advisable to continue studying the antitumor oncolytic and immunomodulatory effects of viral strains 17D YF and Sofjin TBEV using in vivo models.https://virusjour.crie.ru/jour/article/viewFile/16100/850oncolytic virusesflavivirusesyellow fever virustick-borne encephalitis virusglioblastoma cellpancreatic carcinoma cellvirus sensitivityviral oncolysis
spellingShingle Alina S. Nazarenko
Yulia K. Biryukova
Ekaterina O. Orlova
Kirill N. Trachuk
Alla L. Ivanova
Alla V. Belyakova
Nikolai B. Pestov
Mikhail F. Vorovitch
Aydar A. Ishmukhametov
Nadezhda M. Kolyasnikova
Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
Вопросы вирусологии
oncolytic viruses
flaviviruses
yellow fever virus
tick-borne encephalitis virus
glioblastoma cell
pancreatic carcinoma cell
virus sensitivity
viral oncolysis
title Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
title_full Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
title_fullStr Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
title_full_unstemmed Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
title_short Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
title_sort investigation of oncolytic potential of vaccine strains of yellow fever and tick borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines
topic oncolytic viruses
flaviviruses
yellow fever virus
tick-borne encephalitis virus
glioblastoma cell
pancreatic carcinoma cell
virus sensitivity
viral oncolysis
url https://virusjour.crie.ru/jour/article/viewFile/16100/850
work_keys_str_mv AT alinasnazarenko investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT yuliakbiryukova investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT ekaterinaoorlova investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT kirillntrachuk investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT allalivanova investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT allavbelyakova investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT nikolaibpestov investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT mikhailfvorovitch investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT aydaraishmukhametov investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines
AT nadezhdamkolyasnikova investigationofoncolyticpotentialofvaccinestrainsofyellowfeverandtickborneencephalitisvirusesagainstglioblastomaandpancreaticcarcinomacelllines